2013 Japanese Hospital Microbiology Testing Market
NEW YORK, Jan. 17, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p01083065/2013-Japanese-Hospital-Microbiology-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_DiagnosticThis new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including: · Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. · Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms. · Volume and sales forecasts for 80 microbiology tests performed in Japanese hospital laboratories. · Instrumentation technologies and feature comparison of leading analyzers. · Sales and market shares of leading suppliers. · Emerging diagnostic technologies and their potential market applications. · Product development opportunities. · Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. · Business opportunities and strategic recommendations for suppliers. Contains 891 pages and 75 tables Table of Contents Introduction Worldwide Market and Technology Overview A. Major Infectious Disease Tests 1. AIDS a. Background b. Diagnostic Tests c. Vaccines and Drugs 2. Adenovirus a. Background b. Diagnostic Tests c. Vaccines and Drugs d. Adeno-Associated Viruses(AAV) 3. Aeromonas a. Background b. Diagnostic Tests c. Vaccines and Drugs 4. Anthrax/Bacillus Anthracis a. Background b. Diagnostic Tests c. Vaccines and Drugs 5. Arboviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 6. Babesiosis a. Background 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea) a. Background b. Diagnostic Tests c. Vaccines and Drugs 8. Blastocystis Hominis
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV